In line with these results, CBX and Ara-C infusions induced a threefold decrease in BM blastosis in untreated mice (50 ± 7% of human CD45+ cells), in which a major splenomegaly was observed in contrast to treated mice (Fig. 7b right). This evidence concerns the gene PTPRC and Splenomegaly.